关于 "Sterol Lipids" 的结果146+ 个结果
筛选:Lipids×
- (±)-Acetylcarnitine chlorideCAS: 2504-11-2
weak cholinergic agonist; intermediates in lipid metabolism
Lipids - (±)-Myristoylcarnitine chlorideCAS: 14919-38-1
cholinergic agonist; important intermediates in lipid metabolism
Lipids
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC41868 | 10-Nitrooleate | 875685-46-4 | Reactive Oxygen Species | ||
A novel endogenous lipid signalling molecule | |||||
| GC41169 | Lipoxin B4 methyl ester | 97589-07-6 | Innate Immunity | ||
A lipid soluble prodrug of LXB4 | |||||
| GC41279 | Sphingosine (d20:1) | 6918-49-6 | Neuroscience | ||
A lipid component of CNS gangliosides | |||||
| GC42649 | 9-Nitrooleate | 875685-44-2 | Reactive Oxygen Species | ||
A novel endogenous lipid signalling molecule | |||||
| GC44270 | N-(α-Linolenoyl) Tyrosine | 259143-19-6 | Fatty Acids | ||
Novel dietary CNS dopamine enhancing lipid | |||||
| GC91610 | VL422 | 2765519-47-7 | Lipids | ||
VL422 is an ionizable cationic lipid. | |||||
| GC91541 | 80-O18 | 1638334-27-6 | Lipids | ||
80-O18 is an ionizable cationic lipid that has been used in the generation of lipid nanoparticles (LNPs) for use in vitro. | |||||
| GC14406 | (±)-Acetylcarnitine chloride | 2504-11-2 | Lipids | ||
weak cholinergic agonist; intermediates in lipid metabolism | |||||
| GC10056 | (±)-Myristoylcarnitine chloride | 14919-38-1 | Lipids | ||
cholinergic agonist; important intermediates in lipid metabolism | |||||
| GC41860 | 1,8-ANS | 82-76-8 | Fatty Acids | ||
A fluorescent probe for lipid-binding proteins | |||||
| GC41142 | Prostaglandin F2α 1,9-lactone | 55314-48-2 | Cyclooxygenase | ||
A lipid-soluble internal ester of PGF2α | |||||
| GC41206 | 14(S)-HDHA | 119433-37-3 | Lipoxygenase | ||
An anti-inflammatory lipid produced by macrophages | |||||
| GC46911 | Beauveriolide I | 154491-55-1 | Cholesterol Metabolism | ||
A cyclodepsipeptide inhibitor of lipid droplet formation | |||||
| GC45260 | (+)-Cloprostenol isopropyl ester | 157283-66-4 | Cyclooxygenase | ||
A more lipid soluble form of (+)-cloprostenol | |||||
| GC44054 | Leukotriene C4 methyl ester | 73958-10-8 | Lipoxygenase | ||
A more lipid soluble formulation of LTE4 | |||||
| GC44055 | Leukotriene D4 methyl ester | - | Leukotrienes | ||
A more lipid soluble formulation of LTD4 | |||||
| GC44056 | Leukotriene E4 methyl ester | - | Leukotrienes | ||
A more lipid soluble formulation of LTE4 | |||||
| GC44445 | N-Oleoyl-L-Serine | 107743-37-3 | Endocannabinoid/Endocannabinoid-like | ||
An endogenous lipid with bone anabolic activity | |||||
| GC91616 | 306-N16B | 2803699-70-7 | Lipids | ||
306-N16B is an ionizable cationic lipid. | |||||
| GC40888 | (±)14(15)-EpEDE methyl ester | - | P450 | ||
A lipid soluble analog of (±)14(15)-EpEDE | |||||
| GC40982 | Resolvin D5 | 578008-43-2 | Neuroscience | ||
A potent anti-inflammatory, pro-resolving lipid mediator | |||||
| GC91611 | CL15F6 | 2766493-40-5 | Lipids | ||
CL15F6 is an ionizable cationic lipid (pKa = 6.75). | |||||
| GC91587 | IM21.7c | 2416939-42-7 | Lipids | ||
IM21.7c is a cationic lipid that has been used in the generation of lipid nanoparticles for the delivery of mRNA in vitro and in vivo. | |||||
| GC91832 | C10-200 | - | Lipids | ||
C10-200 is an ionizable cationic lipid that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vivo. | |||||